The HI assay is considered the gold standard as a correlate of protection for influenza vaccines [2] [3] [4] and has proved to be simple, rapid, and cost-effective. The aim of the assay is to detect antibodies, capable of inhibiting the agglutination between red blood cells and the viral hemagglutinin (HA). 5 The HI titer is expressed as the reciprocal of the highest serum dilution that shows complete inhibition of agglutination. 6 An antibody titer of 40 is generally regarded as a protective threshold level, beyond which there is less than 50% chance of contracting influenza infection. 7 Despite its wide application, the assay has limitations, including low sensitivity for influenza B and avian viruses, inadequacy in the evaluation of live attenuated vaccines and a high degree of variability among laboratories, due to many factors, including the source of reagents (such as red blood cells and receptor-destroying enzyme) and the lack of standardized protocols.
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The SRH assay is a robust technique based on the passive hemolysis of red blood cells, which is mediated by complement and induced by the antibody-antigen complex. The hemolysis produces an easily identifiable "area of hemolysis," which is proportional to the concentration of influenza antibodies, mainly IgG, present in serum samples. 3, 10, 11 The advantages of the SRH assay are the small quantities of influenza virus and serum required, the ability to simultaneously analyze a large number of serum samples without pre-treatment (apart from complement inactivation) and unbiased results available after overnight incubation. 12 In addition, the assay detects small differences in antibody levels, distinguishes differentiates between closely related influenza strains, and is more sensitive for influenza B strains than the HI assay. [12] [13] [14] [15] A hemolysis area of 25 mm 2 or greater is generally considered to be an immunological correlate of protection. 16 Another widely used serological technique is the virus neutralization assay, which is recommended by the World Health Organization (WHO) for the measurement of functional antibodies against highly pathogenic avian viruses 6 and currently included in the EMA guidelines on influenza vaccines. 1 Commonly used in a micro-neutralization (MN) format, this assay detects antibodies at low titers and distinguishes between pre-and post-vaccination titers in paired sera, especially in the case of small (less than 2-fold) differences in titers. 17 The disadvantage lies in the handling of wildtype viruses, which, in the case of highly pathogenic strains, require high-level facilities. The assay suffers from high interlaboratory variability, owing to the lack of common reference protocols and discrepancies in endpoint determination. Here, MN titer is expressed as the reciprocal of the serum dilution showing at least 50% inhibition of cytopathic effect in mammalian cell culture. 7, 18 To date, no correlates of protection have been established for the MN assay.
In addition to the traditional immunological techniques, the The four assays identify different sets or subsets of antibodies.
The HI assay detects antibodies that bind to the viral HA and prevent the virus-red blood cells agglutination by blocking the receptor binding site; the MN assay identifies functional neutralizing antibodies, including those that recognize epitopes in the stem region of HA, which are conserved among different subtypes of influenza A viruses. 17, 20, 27 Consequently, the MN assay could be less specific in adults and elderly subjects with extensive previous exposure to influenza viruses. 27 However, MN is more sensitive than HI, particularly in detecting low-titer seroconversions. A combination of assays could improve the sensitivity and specificity of influenza vaccine evaluation.
The SRH assay may recognize antibodies not only against the surface glycoproteins but also those against the internal antigens, leading to a potential lack of specificity to antibodies against HA. Few previous studies have dealt with the correlations among the four assays.
The aim of this study was to establish the correlations among the four immunological assays: HI, SRH, MN, and ELISA using four egggrown seasonal influenza strains.
| MATERIAL S AND ME THODS

| Virus antigens
The virus antigens and infectious influenza viruses were seasonal 
| Serum samples
Human serum samples (n = 450) from adults were obtained from Human serum without IgA, IgM, and IgG was used as negative controls (Sigma-Aldrich, S5393).
| Hemagglutination inhibition assay
All serum samples, including the sheep serum samples and negative control, were pre-treated with receptor-destroying enzyme (RDE) (ratio 1:5) from Vibrio Cholerae (Sigma-Aldrich, Milan, Italy)
for 18 hours at 37°C in a water bath and then heat-inactivated for 1 hour at 56°C in a water bath with 8% sodium citrate (ratio 1:4).
Fresh turkey red blood cells were centrifuged twice, washed with a saline solution (0.9%), and adjusted to a final dilution of 0.35%.
From an initial dilution of 1:10, serum samples were 2-fold diluted in duplicate with saline solution (0.9%) in a 96-well plate; 25 μL of standardized viral antigen (4 HA units/25 μL) was added to each well, and the mixture was incubated at room temperature for 1 hour.
Red blood cells were added and, after 1-hour incubation at room temperature, the plates were evaluated for the presence of agglutination inhibition.
The antibody titer was expressed as the reciprocal highest serum dilution that showed complete inhibition of agglutination. As the starting dilution was 1:10, the lower limit of the detectable antibody titer was 10. When the titer was below the detectable threshold, the results were conventionally expressed as 5 for calculation purposes, half the lowest detection threshold.
| Single radial hemolysis assay
Before being used in the SRH assay, serum samples were heat- 
| Micro-neutralization assay
Madin Darby Canine Kidney (MDCK) cells were maintained for a maximum of 30 passages in EME medium containing 10% fetal bovine serum (FBS), 2 mmol/L L-glutamine, 1% non-essential amino acid solution, and 100 U/mL penicillin-streptomycin. The MDCK cell cultures were grown at 37°C in 5% CO 2 . Serum samples, previously heat-inactivated at 56°C for 30 minutes, were diluted 2-fold with EMEM culture medium supplemented with 0.5% FBS in a 96-well plate, mixed with an equal volume of virus (100 TCID 50 /well), and incubated for 1 hour at 37°C in 5% CO 2 . At the end of incubation, the MDCK cell suspension (1.5 × 10 5 cells/mL) was added to the plates, which were then stored in an incubator (37°C, 5% CO 2 ) for 5 days.
After incubation, the plates were observed by optical microscopy and evaluated for cytopathic effect. A cytopathic effect higher than 50% indicates infection. The titer was expressed as the inverse of the last dilution that showed inhibition of cytopathic effect.
| ELISA
To evaluate humoral responses, the ELISA was performed on human 
| Statistical analysis
All statistical analyses were performed using Microsoft R-Open, 
| RE SULTS
The human serum samples (n = 450) were tested by HI, SRH, MN, and ELISA assays to evaluate the assay correlation using Table 1 ).
For the A strains, the correlation between HI, MN, and SRH was stronger than that between ELISA and the other assays. By contrast, 
| D ISCUSS I ON
The immunological response to influenza natural infection or vac- Previous studies involving A strains support the strong agreement between HI and SRH assays found in present study. 11, 14, 28 The correlation between SRH and MN assays observed in this study is in agreement with the findings of the previous studies that used equine influenza strains and H3N2 influenza strain. 11, 29, 30 However, unlike Wang et al, 30 who found much higher correlations between SRH and MN assays than between SRH-HI and HI-MN assays, we found no significant differences among them. however, the difference was small. This could be due to the poor sensitivity of the HI assay to B strains. We found only one previous study of B strains, but this was limited to HI and SRH, which were applied only to the B/Beijing/1/87 strain; this found a statistically significant correlation between the two assays supporting our data.
14 Although ELISA is not officially recognized by the EMA, the technique is able to measure different class-specific IgM, IgA, and IgG antibodies. In addition, the assay is able to measure HA stalkspecific antibodies and could be used to evaluate the immunogenicity of novel universal influenza vaccines. 34 ELISA is particularly suitable for large-scale serological investigation, as it yields unbiased results in a few hours and allows complete automation of the process by high-throughput testing. Our data reveal a positive correlation between ELISA and the other three assays, with lower values for A strains but without differences between A and B strains.
Only two previous studies have evaluated the correlations among ELISA, MN, and HI, and, in agreement with our data, have shown good correlations among them. 31, 32 The present study seems to be ether-treated for the serological diagnosis of influenza B infection; however, this treatment could reduce the specificity of the assay.
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The present study has some limitations, such as missing infor- 
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